Stock CCCC C4 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions C4 Therapeutics, Inc.

Equities

CCCC

US12529R1077

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
6.16 USD -9.41% Intraday chart for C4 Therapeutics, Inc. -8.61% +9.03%
May. 09 Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating MT
May. 08 C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CCCC Stock
  4. Revisions C4 Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW